<sub id="zjj7z"><address id="zjj7z"></address></sub>

<pre id="zjj7z"></pre>

<output id="zjj7z"></output>

<progress id="zjj7z"></progress>

        <rp id="zjj7z"></rp>

          <rp id="zjj7z"><sub id="zjj7z"><strike id="zjj7z"></strike></sub></rp>

          <big id="zjj7z"></big>
          <ins id="zjj7z"></ins>

          <del id="zjj7z"></del>

            <big id="zjj7z"></big>

                   中  文
                  Stock Short Name:Hybio Pharmaceutical | Stock Exchange Code:300199
                  OA系統

                  News

                  More
                  AAPS Annual Meeting and Exposition Nov 9-1...
                  2009.3.18 Professor K.C.Nicolaou visited

                  Company Profile

                  More

                  Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, after over decades of effort, we have grown to be one of the largest and most professional peptide pharmaceutical company in China. We were one of the first to enter the peptide pharmaceutical industry in China, and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services. Our peptide finished dosage is mainly sold in the domestic market, but some of our peptide APIs have been supplied to customers all over the world. Hybio is a GMP-approved pharmaceutical company. Our GMP plant in Shenzhen is a facility occupying an area of more than 1,5000 sq.m. It has been often audited and inspected by local/national s-FDA authorities and by clients all over the world.

                  伊人久久综合热线大杳蕉_色啦啦在线观看免费观看视频_性欧美长高清视频免费